FHIR IG analytics| Package | us.nlm.vsac |
| Resource Type | ValueSet |
| Id | ValueSet-2.16.840.1.113762.1.4.1021.12.json |
| FHIR Version | R4 |
| Source | https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1021.12/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.12 |
| Version | 20250404 |
| Status | active |
| Date | 2025-04-04T01:07:52-04:00 |
| Name | LowMolecularWeightHeparinForVTEProphylaxisIngredientSpecific |
| Title | Low Molecular Weight Heparin for VTE prophylaxis ingredient specific |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: Low Molecular Weight Heparins (LMWH) for VTE prophylaxis as independent ingredients for use in noting the most general idea of this type of therapy. Initial use is for representation of a medication "not done". The desire is to have a single choice.),(Data Element Scope: Medication order or discharge NOT DONE),(Inclusion Criteria: Only single ingredient, ingredient-level representation of LMWHs for VTE prophylaxis),(Exclusion Criteria: None) |
No resources found
| CodeSystem | |
| rxnorm | RxNorm |
No narrative content found in resource
{
"resourceType": "ValueSet",
"id": "2.16.840.1.113762.1.4.1021.12",
"meta": {
"versionId": "15",
"lastUpdated": "2025-04-04T01:07:52.000-04:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "TJC EH Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-keyWord",
"valueString": "Not_In_Use"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2025-04-04"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2025-04-04"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.12",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113762.1.4.1021.12"
}
],
"version": "20250404",
"name": "LowMolecularWeightHeparinForVTEProphylaxisIngredientSpecific",
"title": "Low Molecular Weight Heparin for VTE prophylaxis ingredient specific",
"status": "active",
"date": "2025-04-04T01:07:52-04:00",
"publisher": "TJC EH Steward",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: Low Molecular Weight Heparins (LMWH) for VTE prophylaxis as independent ingredients for use in noting the most general idea of this type of therapy. Initial use is for representation of a medication \"not done\". The desire is to have a single choice.),(Data Element Scope: Medication order or discharge NOT DONE),(Inclusion Criteria: Only single ingredient, ingredient-level representation of LMWHs for VTE prophylaxis),(Exclusion Criteria: None)",
"compose": {
"include": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept": [
{
"code": "67108",
"display": "enoxaparin"
},
{
"code": "67109",
"display": "dalteparin"
},
{
"code": "69646",
"display": "tinzaparin"
}
]
}
]
},
"expansion": {
"identifier": "urn:uuid:866bcc55-6e45-4588-a02e-0cb5f048ad2a",
"timestamp": "2025-05-23T16:46:54-04:00",
"total": 3,
"contains": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "67108",
"display": "enoxaparin"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "67109",
"display": "dalteparin"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "69646",
"display": "tinzaparin"
}
]
}
}